|
|
Oral Abstract: Critical Health Issues in Mothers, Infants, and
Children
Feb 10, 2009 10:00 AM
HIV Incidence in Pregnancy and the
First Postpartum Year and Implications for PMTCT Programs:
Francistown, Botswana, 2008
Lydia Lu, CDC, Atlanta, GA
Effect of
Maternal HAART on Postnatal HIV-1 Transmission after Cessation of
Extended Infant ARV Prophylaxis
Taha Taha, Johns Hopkins University
Bloomberg School of Public Health, Baltimore, MD
Accelerated HIV
Disease Progression in African Infants Co-infected with
Cytomegalovirus
Andrew Prendergast, Univ of Oxford, UK
Lopinavir/ritonavir+Tenofovir/Emtricitabine Is Superior to
Nevirapine+Tenofovir/Emtricitabine for Women with prior Exposure to
Single-dose Nevirapine: A5208 ("OCTANE")
Shahin Lockman Brigham,
Women's Hosppital, Boston, MA
A Phase II Study of the Incidence of
Nevirapine Resistance Mutations in HIV-infected Thai Women Receiving
a Single Intrapartum Dose of NVP followed by a Post-partum Tail of
ZDV/ddI or ZDV/ddI/LPV/r: IMPAACT P1032
Russell Van Dyke, Tulane Univ
Health Sciences Center, New Orleans, LA
Efficacy and Safety of 1-Month
Post-partum Zidovudine and Didanosine to Prevent HIV-1 Nevirapine
Resistance Mutations following Intrapartum Single-dose Nevirapine
Gonzague Jourdain, Res Inst for Devt, Chiang Mai, Thailand; Harvard
School of Public Health, Boston, MA
Prophylactic Effect of
Trimethoprim-Sulfamethoxazole on Malaria in HIV-infected and
-exposed Ugandan Children Living in Settings of High Antifolate
Resistance
Anne Gasasira, Makerere University, Kampala, Uganda
Mortality
and Virological Outcomes of 2105 HIV-infected Children Receiving ART
in Soweto, South Africa
Tammy Meyers, Harriet Shezi Children's
Clinic, Chris Hani Baragwanath Hosp, Univiversity of the Witwatersrand,
Johannesburg, South Africa
Double-dose Lopinavir/Ritonavir Provides
Insufficient Lopinavir Exposure in Children Receiving
Rifampicinbased Anti-TB Treatment
Helen McIlleron, Univiversity of Cape Town,
South Africa
|
